Bronchoscopic EmphysemA Treatment in THE NetherLands
Recruiting now
Conditions studied: COPD
In brief
Rationale: New bronchoscopic treatments for emphysema have shown promise in clinical trials, improving lung function, exercise capacity and possibly survival and are now being adopted by a number of centres in the Netherlands. It is important to ensure that the benefits seen in clinical trials are in fact reflected in clinical practice and that the best use of this early 'real world' experience is made to optimise the development and use of these novel therapies. Overall objective: to develop a national database to record bronchoscopic lung volume reduction procedures for patients with emphysema. This is desirable for audit purposes but will also be an important resource for research both in gathering data and in facilitating collaborations.
Key facts
- Study ID
- NCT02815683
- Run by
- University Medical Center Groningen
- People needed
- 500
- Starts
- 2016-09-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2024-06-14
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves.
You may not qualify if…
- There are no exclusion criteria for this study.
Where it is running
- University Medical Center Groningen — Groningen, Netherlands (enrolling)
- Maastricht University Medical Center — Maastricht, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.